-
CytRx Corp. is a
biopharmaceutical research and
development oncology company based in Los Angeles, California. The
CytRx oncology pipeline includes clinical...
- proteins,
called aggregates, are
thought to play a role in many diseases,
CytRx believes that
arimoclomol could treat a
broad range of diseases.[medical...
-
Zhongrun (1989– )
CureVac (2000– )
Cyclacel (1997– )
Cytokinetics (1997– )
CytRx (1985– )
Daewoong (1945– )
Daiichi Sankyo (2005– )
Danco (2000– ) Darou...
-
changed the name to RXi
Pharmaceuticals Corporation. RXi was a
subsidiary of
CytRx Corp.,
which provided $15
million in
financing in
April 2007. RXi was founded...
- an
experimental cancer drug
developed by
Nippon Shinyaku and
licensed to
CytRx. It is an
inhibitor of Lyn and Bcr-Abl. It
reached phase II
clinical trials...
-
unrivalled specificity which suggests the
probability of
fewer adverse effects.
CytRx has
bafetinib in
phase II
clinical trial as a
treatment for
leukemia as...
- Pharmaceuticals,
acquired by
Pfizer ILY – Ilypsa,
acquired by
Amgen in 2007 INNO –
CytRx ION –
Ionis IPI –
Infinity Pharmaceuticals, Inc ISIS – Isis Pharmaceuticals...
- (INNO-206) is a tumor-targeted
doxorubicin conjugate in
development by
CytRx. Specifically, it is the (6-maleimidocaproyl)
hydrazone of doxorubicin....
- Aéreas VOE
CRUISER Brazil CTY
Cryderman Air
Service CENTURY United States CYT Crystal Shamrock Airlines CRYSTAL-AIR
United States IRO CSA Air IRON AIR...
-
furan is then
formed via
oxidation and
subsequent cyclization catalyzed by a
Cyt p-450
monoxygenase to
afford spectinabillin. Kakinuma, K.; Hanson, C.A.;...
